CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-12 | ADAMS STREET PARTNERS LLC 10% owner | Purchase | +87,668 | $8.50 | $745K | 87,668 |
| 2018-03-12 | ADAMS STREET PARTNERS LLC 10% owner | Purchase | +126,806 | $8.50 | $1.1M | 126,806 |
| 2018-03-12 | Gould Terry P Director | Purchase | +69,864 | $8.50 | $594K | 69,864 |
| 2018-03-12 | Gould Terry P Director | Purchase | +236,128 | $8.50 | $2.0M | 236,128 |
| 2018-03-12 | Gould Terry P Director | Purchase | +67,769 | $8.50 | $576K | 67,769 |
| 2018-03-12 | Gould Terry P Director | Purchase | +87,668 | $8.50 | $745K | 87,668 |
| 2018-03-12 | Gould Terry P Director | Purchase | +126,806 | $8.50 | $1.1M | 126,806 |
| 2018-03-12 | MILLER RICHARD A MD President and CEO | Purchase | +100,000 | $8.50 | $850K | 1,112,293 |
| 2018-01-19 | Buggy Joseph J EVP Discovery Research | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2017-12-13 | Verner Erik J. V.P., Chemistry Research | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-12-13 | Jones William Benton See Remarks | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2017-12-13 | Hunt Daniel W. SVP, Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2017-12-13 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2017-12-13 | MILLER RICHARD A MD President and CEO | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2017-11-20 | MILLER RICHARD A MD President and CEO | Purchase | +10,000 | $10.79 | $108K | 1,012,293 |
| 2017-06-23 | Novo Holdings A/S 10% owner | Purchase | +20,000 | $10.95 | $219K | 3,244,046 |
| 2017-06-13 | MILLER RICHARD A MD President and CEO | Purchase | +2,500 | $9.75 | $24K | 999,793 |
| 2017-06-13 | MILLER RICHARD A MD President and CEO | Purchase | +2,500 | $10.14 | $25K | 1,002,293 |
| 2017-06-12 | MILLER RICHARD A MD President and CEO | Purchase | +11,216 | $9.82 | $110K | 997,293 |
| 2017-06-09 | MILLER RICHARD A MD President and CEO | Purchase | +5,000 | $9.95 | $50K | 982,293 |
Page 13 of 19 · 371 trades